Human papillomavirus, Chlamydia trachomatis, and other risk factors associated with cervical cancer in china

International Journal of Clinical Oncology

Volumn 3, Issue 2, 1998, Pages 81-87

  Dong, Yu Zhen ^a   Sasagawa, Toshiyuki ^a   Fang, Shu Yuen ^b   Yamazaki, Hiroshi ^a   Sakaike, Jun ^a   Jiang, A Ying ^c   Song, Lin ^d   Gou, Mei Tu ^e   Inoue, Masaki ^a  

^a KANAZAWA UNIVERSITY   (Japan)

^b CHINA MEDICAL UNIVERSITY   (China)

^c LIAONING CANCER HOSPITAL AND INSTITUTE   (China)

^d Shen yang Adult Medical College   (China)

^e Department of Obstetrics   (China)

Author keywords

Cervical cancer; Chlamydia trachomatis; Human papillomavirus; Polymerase chain reaction; Risk factors

Indexed keywords

BACTERIAL DNA; VIRUS DNA;

ADULT; AGED; ARTICLE; CANCER RISK; CASE CONTROL STUDY; CHINA; CHLAMYDIA TRACHOMATIS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RISK FACTOR; UTERINE CERVIX CANCER; UTERINE CERVIX CYTOLOGY; WART VIRUS;

EID: 0031806167     PISSN: 13419625     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02492852     Document Type: Article

References (38)

1. Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of eighteen major cancers in 1985. Int J Cancer 1993;54:594-606.
2. Zur Hausen H. Papillomavirus in anogenital cancer as a model to understand the role of viruses in human cancer. Cancer Res 1989;49:4677-4681.
3. Bernard HU, Chan SY and Manos MM. Identification and assessment of known and novel human papillomaviruses by polymerase chain reaction amplification, restriction fragment length polymorphism, nucleotide sequence, and phylogenetic algorithms. J Infec Dis 1994;170:1077-1085.
4. Lorincz AT, Reid R, Jenson AB, Greenberg MD, Lancaster W, Kurman RJ. Human papillomavirus infection of the cervix: relative risk associations of fifth common anogenital types. Obstet Gynecol 1992;79:328-337.
5. De Roda Husman AM, Walboomers J M, Meijer CJ, Risse EK, Schipper ME, Heimerhorst TM, Bleker OP, Delius H, van den Brule AJ, Snijders PJ. Analysis of cytomorphologically abnormal cervical scrapes for the presence of 27 mucotropic human papillomavirus genotypes, using polymerase chain reaction. Int J Cancer 1994;56:802-806.
6. Matsukura T, Sugase M. Identification of genital human papillomaviruses in cervical biopsy specimens: segregation of specific virus types in specific clinicopathological lesions. Int J Cancer 1995;61:13-22.
7. Bosch FX, Manos MM, Munoz N, Sherman M, Jansen AM, Peto J, Schiffman MH, Moreno V, Kurman R, Shah KV. International biology study on cervical cancer (IBSCC) study group. Prevalence of human papillomavirus in cervical cancer: worldwide perspective. J Natl Cancer Inst 1995;87:796-802.
8. Bauer HM, Hildesheim A, Schiffman MH. Determination of human papillomavirus infection in low-risk women in Portland, Oregon. Sex Transm Dis 1993;20:274-278.
9. Becker TM, Wheeler CM, Mcgough NS, Jordan SW, Dorin M, Miller J. Cervical papillomavirus infection and cervical dysplasia in Hispanic, Native American, and non-Hispanic white women in New Mexico. Am J Public Health 1991;81:582-586.
10. Wheeler CM, Parmenter CA, Hunt WC, Becker TM, Greer CE, Hildesheim A, Manos MM. Determination of genital human papillomavirus infection among cytologically normal women attending the University of New Mexico student health center. Sex Transm Dis 1993;20:286-289.
11. Wu AR. Relation between female genital human papillomavirus (HPV) infection and cancer of uterine cervix in Xiang Yuan County, high incidence area of cervical carcinoma. Chung Hua Chung Liu Tsa Chih 1992;14:293-296.
12. Tang XL. Investigation of infection with human papillomavirus in areas of high and low incidences of cervical carcinoma in Sichuan Province. Chung Hua Fu Chan Ko Tsa Chih (Chin J Obstet Gynecol) 1992;27-.379-380.
13. Zhang W. Relative risk analysis of the development of cervical noncancer lesion and cervical carcinoma associated with HPV infection. Chung Hua Liu Hsing Ping Hsueh Tsa Chih (Chin J Epidemiol) 1993;14:300-303.
14. Chan MKM, Lau KM, Tsui Y, Phil M, Wong FWS, Fracog M, Huang DP. Human papillomavirus infection in Hong Kong Chinese women with normal and abnormal cervixdetection by polymerase chain reaction method on cervical scrapes. Gynecol Oncol 1993;60:217-223.
15. Wang PD, Lin RS. Risk factors for cervical intraepithelial neoplasia in Taiwan. Gynecol Oncol 1996;62:10-18.
16. Hu W, Gu MA. Study on the relationship between cervical carcinoma, dysplasia and sexually transmitted diseases. Chung Hua Fu Chan Ko Tsa Chih (Chin J Obstet Gynecol) 1995;30:547-549.
17. Dillner J, Kallings I, Brihmer C, Sikstrom B, Koskela P, Lehtinen M, Schiller JT, Sapp M, Mardh PA. Seropositivities to human papillomavirus types 16, 18, or 33 capsid and to Chlamydia trachomatis are markers of sexual behavior. J Infect Dis 1996;173:1394-1398.
18. Koutsky LA, Holmes KK, Critchlow GW, Stevens CE, Paavonen J, Beckmann AM, DeRouen TA, Galloway DA, Vernon D, Kiviat NBA. Cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection. N Engl J Med 1992;327:1272-1278.
19. De Sanjose S, Munoz N, Bosch FX, Reimann K, Pedersen NS, Orfila J, Ascunce N, Gonzalez LC, Tafur L, Gili M. Sexually transmitted agents and cervical neoplasia in Colombia and Spain. Int J Cancer 1994;56:358-363.
20. Munoz N, Bosch FX, de Sanjose S, Vergara A, del Moral A, Munoz MT, Tafur L, Gili M, Izarzugaza I, Viladiu P. Risk factors for cervical intraepithelial neoplasia grade III/ carcinoma in situ in Spain and Colombia. Cancer Epidemiol Biomarkers Prev 1993;2:423-431.
21. Bosch FX, Castellsague X, Munoz N, de Sanjose S, Gaffari AM, Gonzalez LC, Gill M, Izarzugaza I, Viladiu P, Navarro C, Vergara A, Ascunce N, Guerrero E, Shah KV. Male sexual behavior and human papillomavirus DNA: key risk factors for cervical cancer in Spain. J Natl Cancer Inst 1996;88:1060-1067.
22. Scully RE, Bonfiglio TA, Kurman RJ, Silverberg SG, Wilkinson EJ, eds. Histological typing of female genital tract tumours. World Health Organization International Histological Classification of Tumours. Geneva, Switzerland: Springer-Verlag; 1994.
23. Fujinaga Y, Shimada M, Okazawa K, Fukushima M, Kato I, Fujinaga K. Simultaneous detection and typing of genital human papillomavirus DNA using polymerase chain reaction. J Gen Virol 1991;72:1039-1044.
24. Sasagawa T, Dong Y, Saijoh K, Satake S, Tateno M, Inoue M. Human papillomavirus infection and risk determinants for squamous intraepithelial lesion and cervical cancer in Japan. Jpn J Cancer Res 1997;88:376-384.
25. Breslow NE, Day NE. Statistical methods in cancer research, I. The analysis of case-control studies. Lyon, France: International Agency of Research on Cancer; 1980. Scientific Publication no. 32.
26. Campos-Filho N, Franco ELA. Microcomputer program for multiple logistic regression by unconditional and conditional maximum likelihood methods. Am J Epidemiol 1989;129:439-444.
27. Schneider A, Hotz M, Gissmann L. Increased prevalent human papillomaviruses in the lower genital tracts of pregnant women. Int J Cancer 1987;40:198-211.
28. Rando RF, Lindheim S, Hasty L, Sedlacek TV, Woodland M, Eder C. Increased frequency of detection of human papillomavirus deoxyribonucleic acid in exfoliated cervical cells during pregnancy, Am J Obstet Gynecol 1989;161:50-55.
29. Fife KH, Katz BP, Roush J, Handy VD, Brown DR, Hansell R. Cancer-associated human papillomavirus types are selectively increased in the cervix of women in the first trimester of pregnancy. Am J Obstet Gynecol 1996;174:1487-1493.
30. Kemp AE, Hakenewerth AM, Laurent SL, Gravitt PE, Stoerker J. Human papillomavirus prevalence in pregnancy. Obstet Gynecol 1992;79:649-656.
31. De Roda Husman AM, Walboomers J M, Hopman E, Bleker OP, Heimerhorst TM, Rozendaal L, Voorhorst FJ, Meijer CJ. HPV prevalence in cytomorphologically normal cervical scrapes of pregnant women as determined by polymerase-chain reaction: the age-related pattern. J Med Virol 1995;46:97-102.
32. Melkert PW, Hopman E, van den Brule AJ, Risse EK, van Diest PJ, Bleker OP, Helmerhorst T, Schipper ME, Meijer CJ, Walboomers JM. Prevalence of HPV in cytomorphologically normal cervical smears, as determined by the polymerase chain reaction, is age-dependent. Int J Cancer 1993;53:919-923.
33. Figueroa JP, Ward DE, Luthi TE, Vermund SH, Brathwaite AR, Burk RD. Prevalence of human papillomavirus among STD clinic attendees in Jamaica: association of younger age and increased sexual activity. Sex Transm Dis 1995;22:114-118.
34. Nakazawa A, Inoue M, Fujita M, Tanizawa O, Hakura A. Detection of human papillomavirus type 16 in sexual partners of patients having cervical cancer by polymerase chain reaction. Jpn J Cancer Res 1991;82:1187-1190.
35. Inoue M, Nakazawa A, Tanizawa O, Hakura A. Human papillomavirus (HPV) type 16 in semen of partners of women with HPV infection. Lancet 1992;339:1114-1115.
36. Coker AL, Rosenberg AJ, McCann MF, Hulka BS. Active and passive cigarette smoke exposure to cervical intraepithelial neoplasia. Cancer Epidemiol Biomarkers Prev 1992;1:349-356.
37. Darling JR, Madelein MM, Mcknight B, Carter JJ, Wipf GC, Ashley R, Schwartz SM, Beckmann AM, Hagensee ME, Mandelson MT, Galloway DA. The relationship of human papillomavirus-related cervical tumors to cigarette smoking, oral contraceptive use, and prior herpes simplex virus type 2 infection. Cancer Epidemiol Biomarker Prev 1996;5:541-548.
38. Eluf-Neto J, Booth M, Munoz N, Bosch FX, Meijer CJ, Walboomers JM. Human papillomavirus and invasive cervical cancer in Brazil. Br J Cancer 1994;69:114-119.